Selective chemical inhibition as a tool to study Cdk1 and Cdk2 functions in the cell cycle

被引:16
|
作者
Krasinska, Liliana [1 ]
Cot, Emilie [1 ]
Fisher, Daniel [1 ]
机构
[1] IGMM, CNRS, UMR 5535, Inserm Ave Team Phosphorylat & Control Vertebrate, F-34293 Montpellier 5, France
关键词
cyclin dependent kinase; chemical inhibitors; xenopus; fibroblasts; chromatin; Nu6102; RO-3306;
D O I
10.4161/cc.7.12.6101
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Cyclin-dependent kinases are highly conserved among all eukaryotes, and have essential roles in the cell cycle. However, these roles are still only poorly understood at a molecular level, partly due to the functional redundancy of different Cdk complexes. Indeed, mice knockouts have even thrown into some doubt the assumed essential roles for Cdk2-cyclin E in triggering S-phase, but this is almost certainly due to compensation by Cdk1 complexes. By combining both knockout approaches and chemical Cdk inhibition in Xenopus egg extracts, we have shown that one reason for functional redundancy of Cdk control of S-phase is that Cdk activity required to trigger S-phase is very low. Cdk1 contributes to this activity even in the presence of Cdk2, and Cdk activity at this stage does not show "switch-like" regulation, as at the onset of mitosis. It is important to try to confirm and extend these findings to other cell-types, and to explain why different cells might have evolved different requirements for Cdk activity. In this paper, we present data that suggest that selective chemical Cdk inhibition will be a useful tool towards achieving this goal.
引用
收藏
页码:1702 / 1708
页数:7
相关论文
共 50 条
  • [21] CDK1 and CDK2 regulate NICD1 turnover and the periodicity of the segmentation clock
    Carrieri, Francesca Anna
    Murray, Philip J.
    Ditsova, Dimitrinka
    Ferris, Margaret Ashley
    Davies, Paul
    Dale, Jacqueline Kim
    EMBO REPORTS, 2019, 20 (07)
  • [22] Combined depletion of cdk2, cdk1 and cdk9 activities induces apoptosis in cancer cells
    Cai, Dongpo
    Latham, Vaughan M.
    Zhang, Xinxin
    Shapiro, Geoffrey I.
    CANCER RESEARCH, 2006, 66 (08)
  • [23] FOXM1c is activated by cyclin E/Cdk2, cyclin A/Cdk2, and cyclin A/Cdk1, but repressed by GSK-3α
    Wierstra, Inken
    Alves, Juergen
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 348 (01) : 99 - 108
  • [24] Unmasking the redundancy between Cdk1 and Cdk2 at G2 phase in human cancer cell lines
    L'Italien, Lawrence
    Tanudji, Marcel
    Russell, Loren
    Schebye, Xiao Min
    CELL CYCLE, 2006, 5 (09) : 984 - 993
  • [25] p12CDK2-AP1/CDK2 in cell cycle control.
    Hu, M.
    Hu, G.
    Hinds, P.
    Wong, D. T. W.
    JOURNAL OF DENTAL RESEARCH, 2003, 82 : B44 - B44
  • [26] Slower CDK4 and faster CDK2 activation in the cell cycle
    Zhang, Wengang
    Liu, Yonglan
    Jang, Hyunbum
    Nussinov, Ruth
    STRUCTURE, 2024, 32 (08)
  • [27] Exploring the selectivity of a ligand complex with CDK2/CDK1: a molecular dynamics simulation approach
    Tripathi, Sunil Kumar
    Singh, Sanjeev Kumar
    Singh, Poonam
    Chellaperumal, Palanisamy
    Reddy, Karnati Konda
    Selvaraj, Chandrabose
    JOURNAL OF MOLECULAR RECOGNITION, 2012, 25 (10) : 504 - 512
  • [28] Prediction of paclitaxel sensitivity by CDK1 and CDK2 activity in human breast cancer cells
    Nakayama, Satoshi
    Torikoshi, Yasuhiro
    Takahashi, Takeshi
    Yoshida, Tomokazu
    Sudo, Tamotsu
    Matsushima, Tomoko
    Kawasaki, Yuko
    Katayama, Aya
    Gohda, Keigo
    Hortobagyi, Gabriel N.
    Noguchi, Shinzaburo
    Sakai, Toshiyuki
    Ishihara, Hideki
    Ueno, Naoto T.
    BREAST CANCER RESEARCH, 2009, 11 (01):
  • [29] 胃癌中CDK1和CDK2的表达及预后意义
    颜伟
    张永红
    何乐亚
    魏欣
    陶德定
    胡俊波
    龚建平
    中国组织化学与细胞化学杂志, 2010, 19 (02) : 165 - 167
  • [30] Prediction of paclitaxel sensitivity by CDK1 and CDK2 activity in human breast cancer cells
    Satoshi Nakayama
    Yasuhiro Torikoshi
    Takeshi Takahashi
    Tomokazu Yoshida
    Tamotsu Sudo
    Tomoko Matsushima
    Yuko Kawasaki
    Aya Katayama
    Keigo Gohda
    Gabriel N Hortobagyi
    Shinzaburo Noguchi
    Toshiyuki Sakai
    Hideki Ishihara
    Naoto T Ueno
    Breast Cancer Research, 11